ALAMAR BIOSCIENCES INC (ALMR)
Health Care · Proteomics instruments and consumables · NASDAQ
Alamar Biosciences is a commercial-stage proteomics company providing ultra-sensitive protein biomarker detection instruments and consumables for research and diagnostics.
What ALAMAR BIOSCIENCES INC does
Alamar Biosciences is a commercial-stage proteomics company that has developed proprietary NULISA technology for detecting protein biomarkers at extremely low concentrations in biological fluids such as blood. The company's integrated platform consists of proprietary instruments (ARGO HT System, launched January 2024), consumables, and analytical software designed for scientists across discovery, translational research, and diagnostics. With over 100 instruments installed across 25 countries and over 300 customers, the company is developing a second instrument, the ARGO HT/DX, intended for FDA submission in 2027 as an in vitro diagnostic device.
Themes: ["Proteomics / protein biomarker analysis","Precision diagnostics","Drug discovery / development support","Research instrumentation","In vitro diagnostics (IVD)","Neurodegenerative disease biomarkers"]
Fundamentals
- Price$26.48 as of 2026-07-09 close
- Market cap$1.8B as of 2026-07-10
- 1-year return+15.0% as of 2026-07-09 close
- Net margin-40.2% as of 2026-07-10
- Gross margin+56.2% as of 2026-07-10
- ROE-39.2% as of 2026-07-10
- Debt / equity1.32 as of 2026-07-10
- Beta-2.90 as of 2026-07-10
Key risks (from latest filing)
["Company is unprofitable with -40% net margin and depends on continued customer adoption and pull-through revenue growth from its installed base","ARGO HT/DX instrument intended for FDA submission in 2027 carries regulatory approval risk and development delays could impact future IVD revenue","Heavy dependence on academic institutions (56% of Q1 2026 revenue) and biopharmaceutical customers; concentration in North America and EMEA regions leaves exposure to geographic and sector-specific downturns"]
Competitors & peers
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Luminex Corporation
- Olink Proteomics
- SomaLogic
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.